Status:
COMPLETED
Sinew Acupuncture for de Quervain's Tenosynovitis
Lead Sponsor:
The University of Hong Kong
Conditions:
de Quervain's Tenosynovitis
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
Background: Prevalence of de Quervain's Tenosynovitis (dQt) is estimated at 0.5% among men and 1.3% among women. As there is an increasing length of time in smart phone usage, the prevalence is belie...
Eligibility Criteria
Inclusion
- people aged ≥18 years who have clinically diagnosed de Quervain's Tenosynovitis on one or both wrists based on the discrete tenderness of the first extensor compartment and a positive Finkelstein test.
- pain persisting for ≥3 months,
- with an average ≥40 mm in VAS in the week prior to the screening visit.
Exclusion
- subjects who have possible traumatic or neoplastic origin of symptoms, subjects who have uncontrolled concomitant disease (such as diabetes mellitus or coagulopathy),
- prior treatment in the last 4 weeks with acupuncture, Tuina, physiotherapy, extracorporeal shock wave therapy, low-level laser therapy, steroid injection and/or surgery at the same anatomical location,
- inability to fill in follow-up forms or absence of self-determination in the participating patient.
- subjects who are pregnant.
- serious mental problem, SLUMS≤19
Key Trial Info
Start Date :
June 6 2018
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
September 1 2019
Estimated Enrollment :
68 Patients enrolled
Trial Details
Trial ID
NCT03472443
Start Date
June 6 2018
End Date
September 1 2019
Last Update
July 29 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
The Hong Kong Tuberculosis, Association The University of Hong Kong Clinical Centre for Teaching and Research in Chinese Medicine
Aberdeen, Hong Kong